HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-SEP-11 3TZ8 TITLE KINASE DOMAIN OF CSRC IN COMPLEX WITH RL104 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 251-533; COMPND 5 SYNONYM: PROTO-ONCOGENE C-SRC, PP60C-SRC, P60-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: SRC, V-SRC SARCOMA VIRAL ONCOGENE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSKB3 KEYWDS TYPE II, ALLOSTERIC, DFG-OUT, DRUG RESISTANCE MUTATIONS, TYROSIN- KEYWDS 2 PROTEIN KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.GRUETTER,A.RICHTERS,D.RAUH REVDAT 2 01-NOV-23 3TZ8 1 REMARK SEQADV REVDAT 1 10-OCT-12 3TZ8 0 JRNL AUTH A.RICHTERS,M.GETLIK,C.GRUETTER,R.SCHNEIDER,J.M.HEUCKMANN, JRNL AUTH 2 S.HEYNCK,M.L.SOS,R.K.THOMAS,D.RAUH JRNL TITL OVERCOMING GATEKEEPER MUTATIONS IN CSRC AND ABL BY HYBRID JRNL TITL 2 COMPOUND DESIGN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 20008 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 801 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1315 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2690 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.3420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4195 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 80 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.98 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.36000 REMARK 3 B22 (A**2) : -0.40000 REMARK 3 B33 (A**2) : -1.36000 REMARK 3 B12 (A**2) : 0.16000 REMARK 3 B13 (A**2) : -0.36000 REMARK 3 B23 (A**2) : 1.13000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.337 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.241 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 22.836 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.883 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4407 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5982 ; 1.136 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 520 ; 5.285 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 194 ;37.667 ;23.814 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 745 ;16.524 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;18.463 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 629 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3363 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1978 ; 0.193 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3019 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 200 ; 0.132 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 38 ; 0.212 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.128 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2697 ; 0.433 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4223 ; 0.775 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2025 ; 0.879 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1759 ; 1.506 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3TZ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-OCT-11. REMARK 100 THE DEPOSITION ID IS D_1000068105. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.977032 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : DYNAMICALLY BENDABLE MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20010 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 2.260 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.21 REMARK 200 R MERGE FOR SHELL (I) : 0.16800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.070 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 1.3.1 REMARK 200 STARTING MODEL: PDB ENTRY 3F3V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG 20000, 15% GLYCEROL, 100MM REMARK 280 MES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ALA A 256 REMARK 465 ALA A 408 REMARK 465 ARG A 409 REMARK 465 LEU A 410 REMARK 465 ILE A 411 REMARK 465 GLU A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 MET B 250 REMARK 465 GLN B 251 REMARK 465 THR B 252 REMARK 465 GLN B 253 REMARK 465 GLY B 254 REMARK 465 LEU B 255 REMARK 465 ALA B 408 REMARK 465 ARG B 409 REMARK 465 LEU B 410 REMARK 465 ILE B 411 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 257 CG CD CE NZ REMARK 470 LEU A 407 CG CD1 CD2 REMARK 470 ARG A 469 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 257 CG CD CE NZ REMARK 470 GLU B 331 CG CD OE1 OE2 REMARK 470 LYS B 423 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 289 -35.10 -134.19 REMARK 500 ARG A 385 -21.32 84.01 REMARK 500 ASP A 386 47.51 -146.88 REMARK 500 GLU A 486 -7.76 81.21 REMARK 500 GLU B 270 -81.97 -112.14 REMARK 500 PRO B 299 106.39 -55.08 REMARK 500 ARG B 385 -24.95 79.40 REMARK 500 PRO B 425 46.11 -76.76 REMARK 500 GLU B 486 -2.81 79.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AQM A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AQM B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3F3V RELATED DB: PDB REMARK 900 RELATED ID: 3F3W RELATED DB: PDB REMARK 900 RELATED ID: 3TZ7 RELATED DB: PDB REMARK 900 RELATED ID: 3TZ9 RELATED DB: PDB DBREF 3TZ8 A 251 533 UNP P00523 SRC_CHICK 251 533 DBREF 3TZ8 B 251 533 UNP P00523 SRC_CHICK 251 533 SEQADV 3TZ8 GLY A 248 UNP P00523 EXPRESSION TAG SEQADV 3TZ8 HIS A 249 UNP P00523 EXPRESSION TAG SEQADV 3TZ8 MET A 250 UNP P00523 EXPRESSION TAG SEQADV 3TZ8 CYS A 345 UNP P00523 SER 345 ENGINEERED MUTATION SEQADV 3TZ8 GLY B 248 UNP P00523 EXPRESSION TAG SEQADV 3TZ8 HIS B 249 UNP P00523 EXPRESSION TAG SEQADV 3TZ8 MET B 250 UNP P00523 EXPRESSION TAG SEQADV 3TZ8 CYS B 345 UNP P00523 SER 345 ENGINEERED MUTATION SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL THR SEQRES 8 A 286 GLU TYR MET SER LYS GLY CYS LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 B 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 B 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 B 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 B 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 B 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL THR SEQRES 8 B 286 GLU TYR MET SER LYS GLY CYS LEU LEU ASP PHE LEU LYS SEQRES 9 B 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 B 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 B 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 B 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 B 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 B 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 B 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 B 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 B 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 B 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 B 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 B 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 B 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 B 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET AQM A 1 49 HET AQM B 1 49 HETNAM AQM N-(4-{[4-({[1-(3-AMINOPHENYL)-3-TERT-BUTYL-1H-PYRAZOL- HETNAM 2 AQM 5-YL]CARBAMOYL}AMINO)PHENYL]AMINO}QUINAZOLIN-6-YL)-3- HETNAM 3 AQM (4-METHYLPIPERAZIN-1-YL)PROPANAMIDE FORMUL 3 AQM 2(C36 H43 N11 O2) FORMUL 5 HOH *80(H2 O) HELIX 1 1 PRO A 263 GLU A 265 5 3 HELIX 2 2 SER A 303 LEU A 308 1 6 HELIX 3 3 LEU A 308 LEU A 317 1 10 HELIX 4 4 LEU A 346 GLY A 352 1 7 HELIX 5 5 MET A 354 LEU A 358 5 5 HELIX 6 6 ARG A 359 ASN A 381 1 23 HELIX 7 7 ARG A 388 ALA A 390 5 3 HELIX 8 8 GLU A 396 LEU A 398 5 3 HELIX 9 9 PRO A 425 THR A 429 5 5 HELIX 10 10 ALA A 430 GLY A 437 1 8 HELIX 11 11 THR A 440 THR A 457 1 18 HELIX 12 12 VAL A 467 ARG A 477 1 11 HELIX 13 13 PRO A 488 TRP A 499 1 12 HELIX 14 14 ASP A 502 ARG A 506 5 5 HELIX 15 15 THR A 508 ASP A 518 1 11 HELIX 16 16 ASP A 518 THR A 523 1 6 HELIX 17 17 PRO B 263 GLU B 265 5 3 HELIX 18 18 SER B 303 LEU B 308 1 6 HELIX 19 19 LEU B 308 LEU B 317 1 10 HELIX 20 20 CYS B 345 GLY B 352 1 8 HELIX 21 21 MET B 354 LEU B 358 5 5 HELIX 22 22 ARG B 359 MET B 380 1 22 HELIX 23 23 ARG B 388 ALA B 390 5 3 HELIX 24 24 GLU B 396 LEU B 398 5 3 HELIX 25 25 PRO B 425 THR B 429 5 5 HELIX 26 26 ALA B 430 GLY B 437 1 8 HELIX 27 27 THR B 440 THR B 457 1 18 HELIX 28 28 VAL B 467 ARG B 477 1 11 HELIX 29 29 PRO B 488 TRP B 499 1 12 HELIX 30 30 ASP B 502 ARG B 506 5 5 HELIX 31 31 THR B 508 ASP B 518 1 11 HELIX 32 32 ASP B 518 THR B 523 1 6 SHEET 1 A 5 LEU A 267 GLN A 275 0 SHEET 2 A 5 GLU A 280 TRP A 286 -1 O VAL A 281 N LEU A 273 SHEET 3 A 5 THR A 290 THR A 296 -1 O THR A 296 N GLU A 280 SHEET 4 A 5 TYR A 335 GLU A 339 -1 O THR A 338 N ALA A 293 SHEET 5 A 5 LEU A 325 VAL A 329 -1 N TYR A 326 O VAL A 337 SHEET 1 B 3 GLY A 344 CYS A 345 0 SHEET 2 B 3 ILE A 392 VAL A 394 -1 O VAL A 394 N GLY A 344 SHEET 3 B 3 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 C 5 LEU B 267 GLN B 275 0 SHEET 2 C 5 GLU B 280 TRP B 286 -1 O VAL B 281 N LEU B 273 SHEET 3 C 5 THR B 290 THR B 296 -1 O ILE B 294 N TRP B 282 SHEET 4 C 5 TYR B 335 GLU B 339 -1 O ILE B 336 N LYS B 295 SHEET 5 C 5 LEU B 325 VAL B 329 -1 N TYR B 326 O VAL B 337 SHEET 1 D 2 ILE B 392 VAL B 394 0 SHEET 2 D 2 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 CISPEP 1 GLU A 332 PRO A 333 0 -0.61 CISPEP 2 GLU B 332 PRO B 333 0 -4.85 SITE 1 AC1 12 LEU A 273 ALA A 293 GLU A 310 VAL A 323 SITE 2 AC1 12 GLU A 339 TYR A 340 MET A 341 ASP A 348 SITE 3 AC1 12 LEU A 393 ALA A 403 ASP A 404 PHE A 405 SITE 1 AC2 15 HOH B 50 HOH B 69 LEU B 273 ALA B 293 SITE 2 AC2 15 GLU B 310 MET B 314 GLU B 339 MET B 341 SITE 3 AC2 15 ASP B 348 TYR B 382 LEU B 393 ALA B 403 SITE 4 AC2 15 ASP B 404 PHE B 405 GLY B 406 CRYST1 42.000 63.580 74.510 79.08 87.69 89.88 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023810 -0.000052 -0.000968 0.00000 SCALE2 0.000000 0.015728 -0.003034 0.00000 SCALE3 0.000000 0.000000 0.013680 0.00000